Government's new health strategy ‘no more than hiding the crisps', Tories say
Under new proposals, retailers could be made to set targets to increase their sales of less fattening products.
Shadow work and pensions secretary Helen Whately said setting mandatory targets for supermarkets was 'nanny state'.
'They had 14 years in opposition to think about what they wanted to do about the NHS, they've had a year in government, and the number one thing in it seems to be hide the crisps,' she told Sky News' Sunday Morning With Trevor Phillips.
'It's obviously the nanny state, but it's also not what people want for the NHS.
'People want to hear how they're going to get to see their GP.
'Telling people what to buy, I think, is not up to government. I believe in personal responsibility.'
Health Secretary Wes Streeting told the same programme the Government will work with supermarkets to help 'nudge people in the right direction'.
'By taking the approach we're taking with supermarkets, they will decide through the combination of where they put their products, how they do price promotions, the reformulation, what products they choose to put on the shelves,' he said.
'They will work with us to make sure that we nudge people in the right direction without any of us even noticing, in the same way that we've nudged the country in the other direction since the 1990s.'
Rejecting suggestions that the idea was too controlling, he said it was different to 'traditional nanny statism, where we regulate more heavily on price, on marketing, on what's sold'.
Labour's 10-year health plan is set to be published next week.
Other changes could include money for hospitals being linked to patient ratings.
According to the Times, part of the proposals will see patients contacted a few weeks after their hospital treatment for feedback.
Based on their responses, money could be diverted to a local 'improvement fund'.
Another proposal could see NHS users awarded points for upping their step count and eating healthily.
Points can then be traded for vouchers, with discounts at supermarkets and coffee shops, according to The Sun.
Hundreds of bodies responsible for overseeing and running parts of the NHS in England are likely to be scrapped as part of the changes.
Mr Streeting has said the current system is too complex and needs reform.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Western Telegraph
an hour ago
- Western Telegraph
Weight loss jabs linked to potentially fatal side effects
Some cases of pancreatitis reported to be linked to GLP-1 medicines (glucagon-like peptide-1 receptor agonists) have been fatal. Data from the medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), shows that since the drugs were licensed there have been hundreds of cases of acute and chronic pancreatitis among people taking GLP-1 medicines. The new weight management medication 'Tirzepatide' (brand name Mounjaro®) is shortly being made available to NHS patients to support weight loss. Access is prioritised for those with the greatest clinical need. You can find out more at: — NHS Cheshire and Merseyside (@NHSCandM) June 24, 2025 This includes: 181 reported cases of acute and chronic pancreatitis linked to tirzepatide – the active ingredient for Mounjaro. Five people died. 116 reported reactions of this kind linked to liraglutide, one of which was fatal. 113 cases of acute and chronic pancreatitis linked to semaglutide – the active ingredient for Ozempic and Wegovy. One person died. 101 reported reactions of this kind linked to exenatide, three people died. 52 reported reactions of this sort linked to dulaglutide and 11 reported reactions lixisenatide. No fatalities were linked to either drug. These cases are not confirmed as being caused by the medicines, but the person who reported them suspected they may be. Review your ICB's local policy about treating patients with tirzepatide (Mounjaro) for weight management in a primary care setting and visit: — We are Primary Care (@PrimaryCareNHS) June 27, 2025 Nonetheless, Yellow Card Biobank project, launched by the MHRA and Genomics England, will see researchers examine whether cases of pancreatitis linked to GLP-1 drugs may be influenced by peoples genetic makeup. The MHRA is calling for people who are taking GLP-1 medicine who have been admitted to hospital due to acute pancreatitis to submit a report to its Yellow Card scheme. When a Yellow Card report is received, the MHRA will contact patients to ask if they would be willing to take part in the study. Patients will be asked to submit more information and a saliva sample which will be assessed to explore whether some people are at a higher risk of acute pancreatitis when taking these medicines due to their genes. GLP-1 agonists can lower blood sugar levels in people living with type 2 diabetes and can also be prescribed to support some people with weight loss. 🧵Weight loss jab roll out 'positive for patients' but with implications for general practice that must be considered. Our Chair Kamila Hawthorne has featured widely in the national press and broadcast media responding to the phased roll-out of Mounjaro prescriptions by NHS… — Royal College of General Practitioners (@rcgp) June 23, 2025 Stress and sleep issues Chronic stress and poor sleep are major weight loss blockers. Stress increases cortisol, a hormone linked to fat retention, especially around the abdomen. Sleep deprivation increases ghrelin (hunger hormone) and decreases leptin (fullness hormone), making you more likely to overeat and less likely to move. You're also more impulsive and less motivated when sleep-deprived, making it harder to stick to your diet and exercise routine. As a solution, prioritise stress management techniques (like mindfulness or journaling), and aim for 7-9 hours of sleep per night. Health conditions and medications Medical issues such as PCOS, diabetes, hypothyroidism, or insulin resistance can all interfere with weight loss. Similarly, certain medications (like antidepressants or steroids) may cause weight gain or inhibit fat loss. If weight loss stalls despite doing everything right, consult your GP to rule out or address any underlying conditions. If you have a known medical condition, it's important to stay up to date with your routine reviews and inform your GP or specialist about any weight loss treatments you're using. Regular follow-up helps ensure your treatment plan remains safe and effective. More Mounjaro news... Recent estimates suggest that about 1.5 million people in the UK are taking weight loss jabs. Health officials have suggested that they can help to turn the tide on obesity, but have stressed they are not a silver bullet and do come with side effects. Most side effects linked to the jabs are gastrointestinal including nausea, constipation and diarrhoea. And the medical regulator recently warned that Mounjaro may make the oral contraceptive pill less effective in some patients. Dr Alison Cave, MHRA's chief safety officer, said: 'Evidence shows that almost a third of side effects to medicines could be prevented with the introduction of genetic testing, it is predicted that adverse drug reactions could cost the NHS more than £2.2 billion a year in hospital stays alone. 'Information from the Yellow Card Biobank will help us to better predict those most at risk of adverse reactions – enabling patients across the UK to receive the safest medicine for them, based on their genetic makeup. 'To help us help you, we're asking anyone who has been hospitalised with acute pancreatitis while taking a GLP-1 medicine to report this to us via our Yellow Card scheme. 'Even if you don't meet the criteria for this phase of the Biobank study, information about your reaction to a medication is always extremely valuable in helping to improve patient safety.' Professor Matt Brown, chief scientific officer of Genomics England, said: 'GLP-1 medicines like Ozempic and Wegovy have been making headlines, but like all medicines there can be a risk of serious side effects. 'We believe there is real potential to minimise these with many adverse reactions having a genetic cause. 'This next step in our partnership with the MHRA will generate data and evidence for safer and more effective treatment through more personalised approaches to prescription, supporting a shift towards an increasingly prevention-focused healthcare system.'
Telegraph
an hour ago
- Telegraph
Ban trans women from female lavatories now, Starmer tells hospitals
Sir Keir Starmer has told hospitals and universities to obey the law and ban transgender women from female lavatories 'as soon as possible'. The Prime Minister said public bodies must stop dragging their feet and comply with April's Supreme Court ruling, which found that trans women are not legally women. The judgment on the meaning of the word sex in the Equality Act means that amenities such as toilets and changing rooms have to be separated by biological sex and not by self-identified gender. But two months on, dozens of NHS trusts and other organisations up and down the country have failed to change their guidance, meaning biological men are still being allowed in women's lavatories and changing rooms. Women's rights groups say this puts female staff at risk because most sexual abuse is carried out by biological men. Now, Sir Keir has lost patience with organisations that are still failing to comply with the law. 'We've accepted the ruling' The Prime Minister said: 'We've accepted the ruling, welcomed the ruling, and everything else flows from that as far as I'm concerned. 'Therefore all guidance of whatever kind needs to be consistent with the ruling and we need to get to that position as soon as possible.' Soon after the ruling, the Equality and Human Rights Commission (EHRC) issued interim guidance that said that in places such as hospitals, shops and restaurants, 'trans women (biological men) should not be permitted to use the women's facilities'. It is now consulting on the details of its guidance, but Baroness Kishwer Falkner, chairman, has said the main thrust of the advice will not change. Despite this, most NHS organisations and universities have said they are waiting for the EHRC guidance before updating their policies. But Sir Keir's comments indicate he has little sympathy with this argument. 'No need to wait for further guidance' Maya Forstater, chief executive of the women's rights charity Sex Matters, said: 'This is an important intervention from the Prime Minister, given the huge number of public bodies failing to implement the Supreme Court judgment and therefore operating outside the law. 'Political leadership is essential if women whose rights are being stolen are not to be forced to turn to the courts, where public bodies will end up losing, at great expense to taxpayers.' She added that the law is clear and there is 'no need to wait for further guidance from the EHRC or anyone else'. A growing number of public bodies are changing their guidance in light of the judgment. The Football Association, for example, has said trans women would be banned from women's sport. The Houses of Parliament announced last week that it had changed its position, saying that visitors should use 'the facilities that correspond to their biological sex'. Trans people were instructed to use gender-neutral lavatories on the estate. However, a large number of public organisations have still not changed their guidance. The ruling is of particular importance for universities, many of which organise sports teams and continue to allow biological men to participate in female sports. 'Not making changes' Leeds University said: 'For the avoidance of doubt, we are not making any changes to how we provide campus facilities. 'We will not do so unless there is clear legal obligation, and we have meaningfully consulted with those most directly impacted. This is about getting things right – not about rushing to respond.' Liverpool University said: 'Any practical implications in applying the ruling to our facilities and activities are not yet clear and along with other universities, we now need to wait for more detailed guidance. 'As such, there are no immediate changes to any university policies.' As for the NHS, a group of eight nurses in Darlington is challenging their health trust's policy over allowing a trans colleague to use the female changing rooms at work. The national body – NHS England – is still to publish guidance on the Supreme Court ruling. The NHS Confederation, which represents trusts, has withdrawn pro-trans guidance but has not yet updated it. Several other regional organisations have indicated their advice will not change, at least for the time being. NHS Sussex said: 'There should be no change in terms of how services are delivered as the NHS nationally considers the judgment. 'Further to this, we understand that the update provided by the Equality and Human Rights Commission has led to concern. NHS Sussex will fully participate in a code of practice consultation when it launches to ensure that the protections of the Equality Act endorsed by the Supreme Court are upheld.'
BreakingNews.ie
2 hours ago
- BreakingNews.ie
Couples experiencing secondary infertility eligible for free IVF treatment
Couples experiencing secondary infertility will be eligible for free fertility treatment including IVF in a Government-funded scheme, the Minister for Health has confirmed. From Monday, couples who already have a child but meet all other access criteria can access publicly funded assisted human reproduction treatment. Advertisement This includes one full cycle of in-vitro fertilisation (IVF) or intra-cytoplasmic sperm injection (ICSI). Minister for Health Jennifer Carroll MacNeill announced updated access criteria, saying: 'Since we introduced publicly funded assisted human reproduction (AHR) treatment in September 2023, close to 2,500 couples have been referred by reproductive specialist consultants, and many have achieved their dream of starting a family. Jennifer Carroll MacNeill. Photo: Niall Carson/PA 'Fertility issues can be devastating, and I am conscious that secondary infertility is a significant issue, with many people facing huge financial and emotional difficulties in their attempts to have a second child. 'I have listened to the requests from parents in this difficult situation, and I am pleased that we are now in a position to make this potentially life-changing treatment available to more people. Advertisement 'With effect from June 30th, 2025, the current access criteria will be extended to include couples with one existing child in their relationship.' She said work is under way to progress the legislation and establish a regulatory authority. The Health (Assisted Human Reproduction) Act 2024 was signed into law by in July last year. A supplementary Bill to deal with issues such as parentage and citizenship in surrogacy arrangements as well as donor-assisted conception is also being worked on. Advertisement Entertainment Katie Price ends IVF journey feeling 'exhausted' w... Read More Ms MacNeill added: 'We are making significant progress in relation to AHR legislation, and formal drafting of the Health (Assisted Human Reproduction) (Amendment) Bill is nearing completion. 'Officials at my department are working closely with officials at the Department of Justice and the Department of Children to finalise the Bill. Intensive work is under way to publish this legislation as soon as is practical. 'One critical piece in the AHR jigsaw is the establishment of a regulatory authority. Good progress has been made in relation to the establishment of the Assisted Human Reproduction Regulatory Authority.'
